カテゴリー： FactMR, 世界, 医療/バイオ

臨床試験用画像の世界市場2023年-2033年：予測・動向・分析・競争状況

◆英語タイトル：Clinical Trial Imaging Market Analysis By Service (Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Others), By Application (Non-alcoholic Steatohepatitis, Oncology, Neurology, Endocrinology, Cardiology, Others), By End User & Region - Global Market Insights 2023–2033

FactMRが発行した調査報告書（FACT23FB012）◆商品コード：FACT23FB012
◆発行会社（リサーチ会社）：FactMR
◆発行日：2023年1月10日
◆ページ数：約170
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：産業装置
◆販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Site License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Fact.MR社の本調査資料は、2023年〜2033年を予測期間とし、世界の臨床試験用画像市場について徹底調査・分析を行ったレポートです。本書では、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景・基礎データポイント、需要分析、サービス別（プロジェクト・データ管理、オペレーショナル画像サービス、読み取り・分析サービス、その他）分析、用途別（非アルコール性脂肪性肝炎、腫瘍学、神経学、内分泌学、その他）分析、エンドユーザー別（受託研究機関、バイオテクノロジー・製薬会社、医療機器メーカー、学術・政府研究機関）分析、地域別（北米、中南米、ヨーロッパ、東アジア、南アジア・オセアニア、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査方法などの情報を提供しています。本書内には、主要参入企業として、Navitas Life Sciences、Parexel International Corporation、Perspectum Diagnosticsなどの情報が含まれています。
・エグゼクティブサマリー
・市場概要
・市場リスク・動向分析
・市場背景・基礎データポイント
・需要分析
・世界の臨床試験用画像市場規模：サービス別
- プロジェクト・データ管理の市場規模
- オペレーショナル画像サービスの市場規模
- 読み取り・分析サービスの市場規模
- その他の市場規模
・世界の臨床試験用画像市場規模：用途別
- 非アルコール性脂肪性肝炎における市場規模
- 腫瘍学における市場規模
- 神経学における市場規模
- 内分泌学における市場規模
- その他における市場規模
・世界の臨床試験用画像市場規模：エンドユーザー別
- 受託研究機関における市場規模
- バイオテクノロジー・製薬会社における市場規模
- 医療機器メーカーにおける市場規模
- 学術・政府研究機関における市場規模
・世界の臨床試験用画像市場規模：地域別
- 北米の臨床試験用画像市場規模
- 中南米の臨床試験用画像市場規模
- ヨーロッパの臨床試験用画像市場規模
- 東アジアの臨床試験用画像市場規模
- 南アジア・オセアニアの臨床試験用画像市場規模
- 中東・アフリカの臨床試験用画像市場規模
・市場構造分析
・競争分析
・仮定
・調査方法

本資料には、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスを通して提示されます。また、読者に実用的な洞察を提供し、熟考して市場の状況を示し、臨床試験用画像における競争レベルを推測するのに役立ちます。

Clinical Trial Imaging Market – Scope of Report

A recent study by Fact.MR on the clinical trial imaging market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering clinical trial imaging.

The study also provides the dynamics responsible for influencing the future status of the clinical trial imaging market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the clinical trial imaging market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of clinical trial imaging across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of clinical trial imaging during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for clinical trial imaging are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global clinical trial imaging market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the clinical trial imaging market during the forecast period.

Country-specific valuation on demand for clinical trial imaging has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of clinical trial imaging, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering clinical trial imaging has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the clinical trial imaging domain.

❖ レポートの目次 ❖

Table of Content
1. Global Market – Executive Summary

1.1. Global Market Overview

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Fact.MR Analysis and Recommendations

2. Global Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Introduction and Definition

3. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on Clinical Trial Imaging

3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices

3.1.3. COVID-19 Impact Benchmark with Previous Crisis

3.1.3.1. Change in Demand

3.1.3.2. Before and After COVID-19 Crisis (Projected)

3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual)

3.1.3.4. Change in Demand post Recovery Period (After Each Crisis)

3.1.4. Impact on Market and Value (US$ Mn)

3.1.4.1. Likely Loss of Value in 2022

3.1.4.2. Mid-term and Long Term Forecast

3.1.4.3. Quarter by Quarter Demand and Recovery Assessment

3.1.5. Anticipated Demand and Value Recovery Curve

3.1.5.1. Likelihood of U-Shape Recovery

3.1.5.2. Likelihood of L-Shape Recovery

3.1.6. Recovery Period Assessment by Key Countries

3.1.7. Recovery Assessment by Key Market Segments

3.1.8. Action Points and Recommendations for Suppliers

3.1.9. Impact on Trade Balance

3.2. Key Trends Impacting the Market

3.3. Formulation and Service Development Trends

4. Market Background and foundation Data Points

4.1. Need of the Hour for Industries

4.2. Industry Wise Industry 4.0

4.3. Strategic Priorities

4.4. Life Cycle Stage

4.5. Importance of Technology

4.6. Use Cases of Clinical Trial Imaging

4.7. Forecast Factors: Relevance and Impact

4.8. Investment Feasibility Matrix

4.9. PESTLE Analysis

4.10. Porter’s Five Forces Analysis

4.11. Market Dynamics

4.11.1. Drivers

4.11.2. Restraints

4.11.3. Opportunity Analysis

4.11.4. Trend

5. Global Market Demand (US$ Mn) Analysis 2018-2022 and Forecast, 2023-2033

5.1. Historical Market Value (US$ Mn) Analysis, 2018-2022

5.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Service

6.1. Introduction / Key Findings

6.2. Historical Market Value (US$ Mn) Analysis By Service, 2018-2022

6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Service, 2023-2033

6.3.1. Project & Data Management

6.3.2. Operational Imaging Services

6.3.3. Reading & Analytical Services

6.3.4. Clinical Trial Design & Consultation Services

6.3.5. System & Technology Support Services

6.4. Market Attractiveness Analysis By Service

7. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Application

7.1. Introduction / Key Findings

7.2. Historical Market Value (US$ Mn) Analysis By Application , 2018-2022

7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2023-2033

7.3.1. Non-alcoholic Steatohepatitis

7.3.2. Oncology

7.3.3. Neurology

7.3.4. Endocrinology

7.3.5. Cardiology

7.3.6. Dermatology

7.3.7. Hematology

7.4. Market Attractiveness Analysis By Application

8. Global Market Analysis 2018-2022 and Forecast 2023-2033, by End User

8.1. Introduction / Key Findings

8.2. Historical Market Value (US$ Mn) Analysis By End User, 2018-2022

8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2023-2033

8.3.1. Contract Research Organizations

8.3.2. Biotechnology & Pharmaceutical Companies

8.3.3. Medical Devices Manufacturers

8.3.4. Academic & Government Research Institutes

8.4. Market Attractiveness Analysis By End User

9. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Region

9.1. Introduction / Key Findings

9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018-2022

9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. East Asia

9.3.5. South Asia & Oceania

9.3.6. Middle East and Africa (MEA)

9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018-2022 and Forecast 2023-2033

10.1. Introduction / Key Findings

10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By Service

10.3.3. By Application

10.4. Market Attractiveness Analysis

10.4.1. By Country

10.4.2. By Service

10.4.3. By Application

11. Latin America Market Analysis 2018-2022 and Forecast 2023-2033

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

11.3.1. By Country

11.3.1.1. Brazil

11.3.1.2. Mexico

11.3.1.3. Rest of Latin America

11.3.2. By Service

11.3.3. By Application

11.3.4. By End User

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Service

11.4.3. By Application

11.4.4. By End User

12. Europe Market Analysis 2018-2022 and Forecast 2023-2033

12.1. Introduction / Key Findings

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

12.3.1. By Country

12.3.1.1. Germany

12.3.1.2. France

12.3.1.3. Italy

12.3.1.4. Spain

12.3.1.5. UK

12.3.1.6. BENELUX

12.3.1.7. Russia

12.3.1.8. Rest of Europe

12.3.2. By Service

12.3.3. By Application

12.3.4. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Service

12.4.3. By Application

12.4.4. By End User

13. East Asia Market Analysis 2018-2022 and Forecast 2023-2033

13.1. Introduction / Key Findings

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

13.3.1. By Country

13.3.1.1. China

13.3.1.2. Japan

13.3.1.3. South Korea

13.3.2. By Service

13.3.3. By Application

13.3.4. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Service

13.4.3. By Application

13.4.4. By End User

14. South Asia & Oceania Market Analysis 2018-2022 and Forecast 2023-2033

14.1. Introduction / Key Findings

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

14.3.1. By Country

14.3.1.1. India

14.3.1.2. Thailand

14.3.1.3. Malaysia

14.3.1.4. Singapore

14.3.1.5. Vietnam

14.3.1.6. ANZ

14.3.1.7. Rest of South Asia & Oceania

14.3.2. By Service

14.3.3. By Application

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Service

14.4.3. By Application

14.4.4. By End User

15. Middle East and Africa Market Analysis 2018-2022 and Forecast 2023-2033

15.1. Introduction / Key Findings

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

15.3.1. By Country

15.3.1.1. GCC Countries

15.3.1.2. South Africa

15.3.1.3. Israel

15.3.1.4. Rest of Middle East and Africa (MEA)

15.3.2. By Service

15.3.3. By Application

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Service

15.4.3. By Application

15.4.4. By End User

16. Market Structure Analysis

16.1. Market Analysis by Tier of Companies

16.2. Market Concentration

16.3. Market Share Analysis of Top Players

16.4. Market Presence Analysis

17. Competition Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Competition Deep Dive

17.3.1. Bioclinica, Inc.

17.3.1.1. Company Overview

17.3.1.2. Service overview

17.3.1.3. SWOT Analysis

17.3.1.4. Key Developments

17.3.2. Biomedical Systems Corporation

17.3.2.1. Company Overview

17.3.2.2. Service overview

17.3.2.3. SWOT Analysis

17.3.2.4. Key Developments

17.3.3. Biotelemetry, Inc.

17.3.3.1. Company Overview

17.3.3.2. Service overview

17.3.3.3. SWOT Analysis

17.3.3.4. Key Developments

17.3.4. Cardiovascular Imaging Technologies, LLC

17.3.4.1. Company Overview

17.3.4.2. Service overview

17.3.4.3. SWOT Analysis

17.3.4.4. Key Developments

17.3.5. ERT Clinical

17.3.5.1. Company Overview

17.3.5.2. Service overview

17.3.5.3. SWOT Analysis

17.3.5.4. Key Developments

17.3.6. Icon PLC

17.3.6.1. Company Overview

17.3.6.2. Service overview

17.3.6.3. SWOT Analysis

17.3.6.4. Key Developments

17.3.7. Image Core Lab

17.3.7.1. Company Overview

17.3.7.2. Service overview

17.3.7.3. SWOT Analysis

17.3.7.4. Key Developments

17.3.8. Intrinsic Imaging LLC

17.3.8.1. Company Overview

17.3.8.2. Service overview

17.3.8.3. SWOT Analysis

17.3.8.4. Key Developments

17.3.9. Ixico PLC

17.3.9.1. Company Overview

17.3.9.2. Service overview

17.3.9.3. SWOT Analysis

17.3.9.4. Key Developments

17.3.10. Lyscaut Medical Imaging Company

17.3.10.1. Company Overview

17.3.10.2. Service overview

17.3.10.3. SWOT Analysis

17.3.10.4. Key Developments

17.3.11. Medical Metrics

17.3.11.1. Company Overview

17.3.11.2. Service overview

17.3.11.3. SWOT Analysis

17.3.11.4. Key Developments

17.3.12. Navitas Life Sciences

17.3.12.1. Company Overview

17.3.12.2. Service overview

17.3.12.3. SWOT Analysis

17.3.12.4. Key Developments

17.3.13. Parexel International Corporation

17.3.13.1. Company Overview

17.3.13.2. Service overview

17.3.13.3. SWOT Analysis

17.3.13.4. Key Developments

17.3.14. Perspectum Diagnostics

17.3.14.1. Company Overview

17.3.14.2. Service overview

17.3.14.3. SWOT Analysis

17.3.14.4. Key Developments

17.3.15. Prism Clinical Imaging

17.3.15.1. Company Overview

17.3.15.2. Service overview

17.3.15.3. SWOT Analysis

17.3.15.4. Key Developments

17.3.16. Quotient Sciences

17.3.16.1. Company Overview

17.3.16.2. Service overview

17.3.16.3. SWOT Analysis

17.3.16.4. Key Developments

17.3.17. Radiant Sage LLC

17.3.17.1. Company Overview

17.3.17.2. Service overview

17.3.17.3. SWOT Analysis

17.3.17.4. Key Developments

17.3.18. Resonance Health

17.3.18.1. Company Overview

17.3.18.2. Service overview

17.3.18.3. SWOT Analysis

17.3.18.4. Key Developments

17.3.19. Worldcare Clinical, LLC

17.3.19.1. Company Overview

17.3.19.2. Service overview

17.3.19.3. SWOT Analysis

17.3.19.4. Key Developments

18. Assumptions And Acronyms Used

19. Research Methodology



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 臨床試験用画像の世界市場2023年-2033年：予測・動向・分析・競争状況(Clinical Trial Imaging Market Analysis By Service (Project & Data Management, Operational Imaging Services, Reading & Analytical Services, Others), By Application (Non-alcoholic Steatohepatitis, Oncology, Neurology, Endocrinology, Cardiology, Others), By End User & Region - Global Market Insights 2023–2033)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 臨床試験用画像の世界市場2023年〜2033年
  • ペプチドベース心臓血管治療薬の世界市場2023年-2033年：予測・動向・分析・競争状況
  • ペプチド治療薬（メタボリックシンドローム用）の世界市場2023年～2033年：予測・動向・分析・競争状況
  • 標準型バルーンカテーテルの世界市場2023年～2033年：予測・動向・分析・競争状況
  • 動物用画像処理装置の世界市場2023年～2033年：予測・動向・分析・競争状況

    • ◆H&Iグローバルリサーチのお客様（例）◆